[go: up one dir, main page]

IE45902L - Antimicrobial composition - Google Patents

Antimicrobial composition

Info

Publication number
IE45902L
IE45902L IE772220A IE222077A IE45902L IE 45902 L IE45902 L IE 45902L IE 772220 A IE772220 A IE 772220A IE 222077 A IE222077 A IE 222077A IE 45902 L IE45902 L IE 45902L
Authority
IE
Ireland
Prior art keywords
erythromycin
antimicrobial composition
ca1090253a
manring
beauregard
Prior art date
Application number
IE772220A
Other versions
IE45902B1 (en
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of IE45902L publication Critical patent/IE45902L/en
Publication of IE45902B1 publication Critical patent/IE45902B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/602—Glycosides, e.g. rutin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Birds (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

ANTI-ACME COMPOSITION Edward David Thompson Stephen Beauregard Carter Gary Lee Manring Compositions for topical application of erythromycin and derivatives of erythromycin comprising ethanol, isopropyl myristate, glycerol monooleate and the erythromycin compounds are especially useful as a treatment for acne. [CA1090253A]
IE2220/77A 1976-11-01 1977-11-01 Anti-acne compositions containing erythromycins IE45902B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US73731576A 1976-11-01 1976-11-01

Publications (2)

Publication Number Publication Date
IE45902L true IE45902L (en) 1978-05-01
IE45902B1 IE45902B1 (en) 1982-12-29

Family

ID=24963418

Family Applications (1)

Application Number Title Priority Date Filing Date
IE2220/77A IE45902B1 (en) 1976-11-01 1977-11-01 Anti-acne compositions containing erythromycins

Country Status (10)

Country Link
JP (1) JPS5394030A (en)
BE (1) BE860349A (en)
CA (1) CA1090253A (en)
DE (1) DE2748399C2 (en)
FR (1) FR2368949A1 (en)
GB (1) GB1587428A (en)
IE (1) IE45902B1 (en)
IT (1) IT1088874B (en)
NL (1) NL179185C (en)
PH (1) PH15370A (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2378523A1 (en) * 1977-01-26 1978-08-25 Grupper Charles ACNE TREATMENT MEDICINE
US4299826A (en) * 1979-10-12 1981-11-10 The Procter & Gamble Company Anti-acne composition
IT1210608B (en) * 1980-12-08 1989-09-14 Rorer Int Overseas COMPOSITION FOR TOPICAL ACNE TREATMENT
JPS5855411A (en) * 1981-09-28 1983-04-01 Nitto Electric Ind Co Ltd Base material composition and medicinal composition for external use
JPH0764754B2 (en) * 1984-10-02 1995-07-12 花王株式会社 Transdermal absorption enhancer and external preparation for skin containing the same
LU86393A1 (en) * 1986-04-16 1987-12-07 Oreal STABLE ANTI-ACNE COMPOSITION BASED ON ERYTHROMYCIN
US4764379A (en) * 1987-08-24 1988-08-16 Alza Corporation Transdermal drug delivery device with dual permeation enhancers
US5260292A (en) * 1991-03-05 1993-11-09 Marvin S. Towsend Topical treatment of acne with aminopenicillins
DE4334553C2 (en) * 1993-10-11 1998-05-20 Synopharm Gmbh Pharmazeutische Liquid pharmaceutical system for percutaneous application
PL2079441T3 (en) * 2007-07-25 2011-02-28 Ixodes Gmbh Topical antibiotic composition for the prevention of lyme disease
JP2024510458A (en) * 2021-03-16 2024-03-07 ユニリーバー・アイピー・ホールディングス・ベスローテン・ヴェンノーツハップ beauty skin care composition

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2914443A (en) * 1958-03-31 1959-11-24 Abbott Lab Ointment
GB903256A (en) * 1958-11-27 1962-08-15 Mundipharma Ag Improvements in novel otologic preparations and the process for their preparation
GB1048820A (en) * 1963-05-29 1966-11-23 Merck & Co Inc Emollient compositions containing liquid fatty acid esters
CA945068A (en) * 1967-10-25 1974-04-09 Albert M. Kligman Composition and method of treating acne
BE793229A (en) * 1971-12-23 1973-06-22 Merck & Co Inc GUANIDINE DERIVATIVES WITH ANTI-ACNE ACTION
GB1538903A (en) * 1975-04-11 1979-01-24 Nelson Res & Dev Carrier for a topically applied physiologically active agent or cosmetic agent

Also Published As

Publication number Publication date
CA1090253A (en) 1980-11-25
FR2368949A1 (en) 1978-05-26
NL179185C (en) 1986-08-01
DE2748399A1 (en) 1978-05-11
IE45902B1 (en) 1982-12-29
JPS5394030A (en) 1978-08-17
NL179185B (en) 1986-03-03
BE860349A (en) 1978-05-02
DE2748399C2 (en) 1983-09-15
PH15370A (en) 1982-12-10
NL7712005A (en) 1978-05-03
IT1088874B (en) 1985-06-10
FR2368949B1 (en) 1979-07-20
GB1587428A (en) 1981-04-01

Similar Documents

Publication Publication Date Title
IL48797A (en) Topical,anti-inflammatory pharmaceutical compositions comprising at least two corticosteroids
AU529061B2 (en) Colloidal aqueous composition
IE45902L (en) Antimicrobial composition
AU505939B2 (en) 6, 7-benzomorphan derivatives
IE800711L (en) 3-alkoxy flavones.
AU6184180A (en) 5,6,7-trinor-4,8-inter-m-phenylene pgi2 derivatives
NZ182186A (en) 2,6-dimethylaniline derivatives and fungicidal compositions
AU505660B2 (en) 3, 4-dihydro-quinazoline derivatives
AU533795B2 (en) Hydrated mg(no3)2 mg cl2 reversible phase, change composition
AU508738B2 (en) 8-oxo-3-oxa-l-azabicycio [4,2,0] - cotane derivatives
CA1003333A (en) Aerosol antiperspirant or deodorant composition comprising 2-ethyl-1,3-diol as an emollient or dispersant
IE790219L (en) Alkanolamine derivatives
AU502296B2 (en) Topical antimicrobial compositions
IL49931A (en) Pharmaceutical compositions comprising 1-phenyl-2,3,4,5-tetrahydro-1h-benzazepine derivatives and certain new such compounds
NZ180657A (en) 3-aminoalkyl-2-phenyl-bicyclo (2.2.2)-octane or-oct-2-ene derivatives,and pharmaceutical compositions
IE39292B1 (en) 17 hydroxy 16,16-dimethylestr-4-en-3-one
AU1651676A (en) Compositions of 1, 2, 4-rhiadiazine derivatives
AU505161B2 (en) 1, 3, 5, 7-tetraaza-4-sulpha-hept-1-en-6-one derivatives
AU4633079A (en) 6,7-benzomorphan derivatives
AU501019B2 (en) 3, -5, - dispiro 1, 2, 4- tritholan compounds
AU505115B2 (en) N, n'diphenyl-guanidine derivatives
AU511156B2 (en) 7, 7-Dimethylnorbornane derivatives
CA1025858A (en) Antimicrobial product, composition and method
AU7842975A (en) Substituted 2-bromo-sb-fluoro-pregna 1,4-diene 3, 2o diones
AU502943B2 (en) 1-hydroxy-benz 0-2, 3, 1-diazaborine derivatives

Legal Events

Date Code Title Description
MM4A Patent lapsed